Stable coronary artery disease

Stable coronary artery disease

poor blood flow to the muscles of the heart (coronary heart disease)

CHD coronary heart disease MI myocardial infarction.

Addition of the contraindications Established ischaemic heart disease and or cerebrovascular

That's what we call coronary artery disease, or heart disease.

Coronary heart disease would be redundant, because coronary is already referring to the heart.

Addition of the contraindications Established ischaemic heart disease and or cerebrovascular

Fatal CHD plus non fatal MI Total cardiovascular events and revascularization procedures Total coronary events

Addition of the contraindications Established ischaemic heart disease and or cerebrovascular

Established ischaemic heart disease, peripheral arterial disease and or cerebrovascular disease.

If any of these apply to you, or if you are not sure, tell your doctor before taking Ketek.

if you have had certain heart problems such as coronary heart disease, ventricular arrhythmias,

Uncommon cardiac failure, angina pectoris, atrial fibrillation, pericardial effusion, coronary artery disease, cardiomegaly, cardiac murmur, bradycardia.

Established ischaemic heart disease, peripheral arterial disease and or cerebrovascular disease.

16 Established ischaemic heart disease, peripheral arterial disease and or cerebrovascular disease.

43 Established ischaemic heart disease, peripheral arterial disease and or cerebrovascular disease.

Established ischaemic heart disease, peripheral arterial disease, and or cerebrovascular disease.

Established ischaemic heart disease, peripheral arterial disease and or cerebrovascular disease.

the rate of a recurrent coronary event (either coronary heart disease death or nonfatal MI) by 24

Major cardiovascular events (fatal and non fatal AMI, silent MI, acute CHD death, unstable angina, CABG, PTCA, revascularization, stroke)

artery bypass grafting or percutaneous transluminal coronary angioplasty) by 20 (p 0.0001)

So heart disease is one of the causes of heart failure.

3.1.4 Exposure to ETS may cause coronary heart disease and lung cancer in adults.

The study investigated a) the effect of simvastatin on mortality, b) the effect of simvastatin on major coronary events, and c) the effect of simvastatin on any coronary event.

Coronary thrombolysis may result in arrhythmias associated with reperfusion.

Hypersensitivity to the active substance or to any of the excipients. Conditions where the effects of Ventavis on platelets might increase the risk of haemorrhage (e. g. active peptic ulcers, trauma, intracranial haemorrhage). Severe coronary heart disease or unstable angina Myocardial infarction within the last six months Decompensated cardiac failure if not under close medical supervision

Overall, 90 of the patients had a previous myocardial infarction and or a previous coronary revascularisation.

The syndrome, the female pattern now is called microvascular coronary dysfunction, or obstruction.

Primary Percutaneous Coronary Intervention (PCI) If primary PCI is scheduled according to the current relevant treatment guidelines, Metalyse as administered in the ASSENT 4 PCI study (see section 5.1) should not be given.

Overall, 90 of the patients had a previous myocardial infarction and or a previous coronary revascularisation.

AMI acute myocardial infarction CABG coronary artery bypass graft CHD coronary heart disease MI myocardial infarction PTCA percutaneous transluminal coronary angioplasty.

The trial population had evidence of coronary artery disease with no evidence of clinical signs of heart failure.

CPMP 6214 03

To be eligible patients had to have had one or more of the following myocardial infarction, stroke, percutaneous cardiac intervention or coronary artery bypass graft, acute coronary syndrome, coronary artery disease, or peripheral arterial obstructive disease.

To be eligibile patients had to have had one or more of the following myocardial infarction, stroke, percutaneous cardiac intervention or coronary artery bypass graft, acute coronary syndrome, coronary artery disease, or peripheral arterial obstructive disease.

To be eligible patients had to have one or more of the following myocardial infarction, stroke, percutaneous cardiac intervention or coronary artery bypass graft, acute coronary syndrome, coronary artery disease, or peripheral arterial obstructive disease.

Especially in patients with serious heart diseases (e. g. severe heart failure, coronary artery disease) cardiovascular reactions may deteriorate.

GERMANY

High Risk of Coronary Heart Disease (CHD) or Existing Coronary Heart Disease In the Heart Protection Study (HPS), the effects of therapy with Zocord were assessed in 20,536 patients (age 40 80 years), with or without hyperlipidaemia, and with coronary heart disease, other occlusive arterial disease or diabetes mellitus.

artery bypass graft surgery or coronary angioplasty) by 37 (p 0.009) and coronary angiography by 31 (p 0.007).

Some scientists believe that the risk of passive smoking, in particular the risk of developing coronary heart diseases, may have been substantially underestimated.

The following undesirable effects had a rate greater than placebo and have been reported among 1543 patients administered Dynastat 20 or 40 mg as a single or multiple dose (up to 80 mg day) in 12 placebo controlled studies, including dental, gynaecologic, orthopaedic surgery or coronary artery bypass graft surgery as well as pre operative administration in dental and orthopaedic surgeries.

If percutaneous coronary intervention (PCI) is performed during INTEGRILIN therapy, the intravenous solution may be continued for up to 96 hours.

artery bypass graft surgery or coronary angioplasty) by 37 (p 0.009) and coronary angiography by 31 (p 0.007).